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OBJECTIVE — Todescribetheimpactofabdominalobesityandhepaticinsulinresistanceon
phase-speciﬁc glycemic responses in older women.
RESEARCH DESIGN AND METHODS — We studied 23 healthy older women
(60–88 years old). Abdominal obesity was deﬁned by an abdominal circumference 95 cm.
Plasma glucose and insulin were measured in response to a 3-h oral glucose tolerance test.
Insulin suppression of hepatic glucose production was determined using in vivo clamp
techniques.
RESULTS — Despite identical prevailing insulin concentrations, glucose excursions 30 min
postchallenge (but not later) were greater in women with abdominal obesity than in those
without (162  19 vs. 132  16 mg/dl; P  0.01). There was a strong correlation between
hepatic glucose production suppression under low-dose insulin infusion and early-phase glu-
cose excursions from the oral glucose tolerance test (r  0.83; P  0.001) in women with
abdominal obesity, but not in women without (r  0.44; P  0.11).
CONCLUSIONS — Abdominal obesity relates speciﬁcally to early-phase hyperglycemia via
hepatic insulin resistance, even in healthy older women.
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T
he relationship of excess abdominal
adiposity to impaired glycemic con-
trol is well established. There are,
however, few data describing the impact
of abdominal fat on the glycemic burden
over speciﬁc phases of the glucose re-
sponse curve so that distinct obesity-
related impairments in insulin secretion,
suppression of hepatic glucose produc-
tion,orimpairmentsinperipheralinsulin
action can be identiﬁed.
RESEARCH DESIGN AND
METHODS— Healthy older (60
years; n  23) women were recruited for
participation in a 9-month aerobic exercise
trial (1,2). Women were reported inactive,
nonsmoking, free of any uncontrolled
chronic disease, and not taking hormone
replacement therapy, glucose-lowering, or
cholesterol-lowering medication. Methods
for determining peak aerobic capacity
(VO2peak) have been previously described
(1,2). For this report, we analyzed baseline
data to determine relations among abdom-
inal obesity and phase-speciﬁc glycemic re-
sponse to an oral glucose challenge. All
clinical procedures were performed in the
Hospital Research Unit of the Yale Center
for Clinical Investigation. Protocols were
approved by the Human Investigations
Committee of Yale University, and all eligi-
ble subjects gave written informed consent
before participation.
Oral glucose tolerance test
A75-goralglucosetolerancetest(OGTT)
was performed according to the guide-
lines of the American Diabetes Associa-
tion (3), with plasma glucose and insulin
concentrations determined by standard
procedures in the Core Laboratory of the
Yale Center for Clinical Investigation.
Several clinical indexes of glucose metab-
olism and insulin resistance were calcu-
lated from the OGTT. Total and 60-min
areas under the glucose (AUCG) and in-
sulin (AUCI) response curves were calcu-
lated by the trapezoidal method. To
evaluate the ability of endogenous insulin
secretiontosuppresshepaticglucosepro-
duction, we calculated the difference in
glucose concentrations between baseline
and 30 min ( glucose30-glucose0)o ft h e
OGTT. The insulinogenic index was cal-
culated as the ratio of insulin to glucose
values between 0 and 30 min [( insu-
lin30-insulin0)/( glucose30-glucose0)]
andusedasanindicatorof-cellfunction
(4). The composite whole-body insulin
sensitivity index was calculated as
[10,000/(glucose0  insulin0)
2  (mean
glucose0  120  mean insulin0  120)]
(5). Insulin suppression of hepatic glu-
cose production (%) was determined
within14daysoftheOGTTinthesesame
older women using [6,6-
2H]glucose dur-
ing a low-dose euglycemic-hyperinsu-
linemic clamp according to methods
recently described (2).
Body composition
The abdominal circumference (centime-
ters)wasmeasuredintriplicateattheum-
bilicus (6) by the same examiner. We
performed a receiver operating character-
istic analysis using both anthropometric
andcomputedtomographydatafromone
of our previous study populations (7) to
determine that the abdominal circumfer-
ence cut point of 95 cm demonstrated the
greatest sensitivity (89%) and the lowest
false-positiveerror(14%)relativetoother
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women as abdominally obese (according
to a visceral fat area 100 cm
2) (6).
Whole-bodyandsite-speciﬁcmuscle(kg)
and fat mass (kg) scans were obtained us-
ing dual-energy X-ray absorptiometry.
Statistical analysis
Study variables demonstrating a statisti-
cally signiﬁcant association with abdomi-
nal obesity (abdominal circumference
95 cm) in the simple analyses (correla-
tion and independent t test) were then
entered into separate multivariable
ANOVA models to test their association
with abdominal obesity independent of
total fat and lean mass.
RESULTS— Women with (n  14)
and without (n  9) abdominal obesity
weresimilarwithregardtoage(745vs.
74  5 years, respectively) and level of
VO2peak (19  4 vs. 21  4m g  kg
1  
min
1,respectively).Totalleanmass(kg)
was similar between the groups (41.0 
6.2 vs. 37.0  6.5 kg), but there was a
marked difference in total body fat
(30.2  5.0 vs. 20.4  7.2 kg) between
those with and without abdominal obesity
(P0.001). The mean abdominal circum-
ference between older women character-
izedwithabdominalobesityandthosewho
werenotwas105.77.3versus81.19.5
cm, respectively (P  0.001).
In addition to signiﬁcant differences
in basal (99  9 vs. 89  8 ml/dl; P 
0.05)and30-min(16219vs.13216
ml/dl; P  0.01) glucose concentrations,
the AUCG from 0 to 60 min was signiﬁ-
cantly higher in women with abdominal
obesity than in those without [89.4 
11.8 vs. 76.2  10.2 (mg   dl
1   60
min
1)   10
2; P  0.01], even though the
prevailing insulin concentrations for that
same time period were identical [AUCI:
20.5  10.1 vs. 20.5  6.3 (U   ml
1  
60min
1) 10
2].Whentheinsulinogenic
indexwasnormalizedforinsulinsensitiv-
ity using the whole-body insulin sensitiv-
ity index, the groups were identical in
their -cell response (insulinogenic index/
whole-body insulin sensitivity index 
0.21  0.19 vs. 0.21  0.13 for those
with and without abdominal obesity, re-
spectively).Importantly,adjustedparam-
eter estimates for glucose responses
between 0 and 60 min were altered little
by the inclusion of either total fat or lean
mass in the ANOVA modeling.
To determine whether these early-
phasedefectsinglucoseresponsewithab-
dominal obesity were modulated by
hepatic insulin resistance, we tested the
associationbetweenthechangeinglucose
concentrations between 0 and 30 min (
glucose30-glucose0) of the OGTT and
suppression (%) of hepatic glucose pro-
duction under low-dose (10 mU) insulin
stimulation. Indeed, among abdominally
obese women, there was a strong inverse
correlation between hepatic glucose pro-
duction suppression and ﬁrst-phase glu-
cose excursions (r  0.83; P  0.001),
which was not apparent in older women
without excess abdominal fat (r  0.44;
P  0.10) (Fig. 1).
CONCLUSIONS— We are not
aware of any data linking abdominal adi-
posity speciﬁcally to ﬁrst-phase defects in
glycemiccontrolinhealthyolderwomen.
Older women with abdominal obesity
demonstrated a signiﬁcantly greater early
(0–30 min) glucose excursion compared
with their leaner counterparts. These dif-
ferences in glycemic response were not
observedoverthelaterphaseoftheOGTT
(60–180 min) and were independent of
age, ﬁtness, and total lean or fat mass.
Since the prevailing insulin concentra-
tions over the ﬁrst 30 min of the OGTT
were similar between the groups, insufﬁ-
cient insulin secretion was possibly not
the primary factor in these ﬁrst-phase de-
fects in glycemic control. These ﬁndings
and others (8–10) support the premise
that an inability of the liver to adequately
inhibit glucose production during early-
phase insulin secretion is the stronger
mechanism(comparedwithaging-related
compromises in -cell function or in
peripheral insulin resistance) relating
abdominal obesity to early-phase hyper-
glycemia in these healthy older women.
We note that although we used a combi-
nation of standard clinical, highly precise
imagingandinvivoprocedures,thesmall
selected sample, as well as the use of the
less traditional abdominal circumference,
mayhavecompromisedthegeneralizabil-
ity of these ﬁndings to the aging popula-
tion at large.
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